​Future of Biotech x AI: AI for Biopharma Research and Development

​An exclusive in-person expert panel co-hosted by Tech Brews, Magnet Ventures, TechBio Transformers. Sponsored by DLA Piper and Singapore Global Network.

​Featuring Special Guests

​Professor Le Cong, Professor at the Pathology and Genetics Departments at Stanford University and a Donald and Delia Baxter Scholar. His lab develops AI co-scientists to accelerate scientific discovery, pioneering platforms such as CRISPR-GPT, RNAGenesis, and LabOS—the first AI-XR system that enables human–AI collaboration in real-world experiments through agentic AI, smart glasses, and robotic perception, paving the way toward a fully autonomous laboratory for science.

​Kristina Kitko, Head of AI investments at Lilly Ventures. Kristina focuses on the U.S. West Coast as part of Eli Lilly's larger corporate business development efforts, primarily targeting early stage innovation across Lilly’s five core therapeutic areas. Prior to Lilly, she worked in corporate strategy at Crinetics Pharmaceuticals and in venture creation at Flagship Pioneering and as an independent consultant. Kristina completed her Ph.D. in pharmacology and electrical engineering from Vanderbilt University as an NSF IGERT fellow, and her postdoctoral training in brain and cognitive sciences across MIT and Harvard.

​Celestine Schnugg, General Partner at Boom Capital Ventures, an early stage venture firm financing scientists and engineers. She is the first investor in Mammoth Biosciences, A-Alpha Bio, Fauna Bio, and Diligent Robotics, and early rounds of Swarm Technologies (acquired by SpaceX), Astra (NASDAQ: ASTR), Planet (NYSE: PL) etc. Prior to Boom, she was at Eric Schmidt's Innovation Endeavors and helped build the sustainability program at Apple. Through Rare Team 6, a multidisciplinary operative, Cece leads efforts to uncover the biological drivers of undiagnosed conditions and build disease-specific biobanks-harnessing the decade's most powerful technologies to cure the incurable by 2035.

​Ali Madani, CEO of Profluent Bio, which decodes the language of life with LLMs. He was previously the architect of the ProGen moonshot at Salesforce AI Research. Ali has a PhD from UC Berkeley and have led work accepted in Nature, NeurIPS, ICLR, and Cell family journals which has also been covered by the NYTimes, WSJ, Fortune, TechCrunch, Forbes, BBC, Endpoints, and Axios.

​Moderator : Darren Platt, Partner at Magnet Ventures

​Event Format

• ​Engaging, candid discussion with the panelists about the application of AI in Biopharma Research and Development

• ​Relaxed networking session with fellow biotech and AI professionals

• ​Enjoy light bites and drinks kindly sponsored by DLA Piper and the Singapore Global Network

​Who Should Attend

​Whether you're a biotech veteran or an AI professional exploring the AI or lifesciences ecosystem, this series provides valuable insights and practical tools by experts to help you excel in your career or as an entrepreneur.

​About the Event Series

​Welcome to the Bay Area edition of the "Future of Biotech x AI" event series! Held quarterly, this event series features an expert panel discussing their hot takes and insights on the future of Biotech and AI. Most suited for biotech professionals, entrepreneurs, and investors to learn, gain insights and network.

​Organizers

​Magnet Ventures focuses on AI-driven biotech investments, specifically on computational approaches to biological drug discovery and therapeutic delivery.

​Tech Brews is an open and inclusive global community for founders and innovators in healthtech, biotech and life sciences. With more than 1000 members globally, Tech Brews hosts regular events including founder fireside chats, investor panels, and startup pitch nights. Tech Brews has chapters in San Francisco, Los Angeles, Singapore, Hong Kong, Japan, Shenzhen, India, South Africa, London, and Dubai.

​TechBio Transformers is a community of scientists, product managers, computational biologists, academics, and engineers who work on the world's most important problems at the intersection of biology, software, and AI.

​Sponsors

​DLA Piper is a law firm with offices in over 40 countries across the Americas, Asia Pacific, Europe, Africa, and the Middle East.

​Singapore Global Network: If you are curious to meet like minded people globally, join SGN's online vibrant community here today. By joining their network, you connect with a 130,000-strong community of professionals and friends seeking to deepen connections in Singapore and across the globe.